PATISIRAN SODIUM | N210922 | ALNYLAM PHARMACEUTICALS INC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2018-00739 | 9364435 | IPR | Moderna Therapeutics, Inc. | Final Written Decision | 2018-03-05 | — |
| IPR2019-00554 | 8058069 | IPR | Moderna Therapeutics, Inc. | Final Written Decision | 2019-01-09 | — |
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8058069 | Apr 15, 2029 | — | — | Yes | — | — |
| 8158601 | Nov 10, 2030 | — | — | Yes | — | |
| 8168775 | Aug 10, 2032 | — | Yes | Yes | — | |
| 8492359 | Apr 15, 2029 | — | — | Yes | — | — |
| 8642076 | Oct 3, 2027 | — | — | Yes | — | — |
| 8741866 | Oct 20, 2029 | — | — | — | — | |
| 8802644 | Oct 21, 2030 | — | — | Yes | — | |
| 8822668 | Apr 15, 2029 | — | — | Yes | — | |
| 9234196 | Oct 20, 2029 | — | — | Yes | — | |
| 9364435 | Apr 15, 2029 | — | — | Yes | — | |
| 10240152 | Oct 20, 2029 | — | Yes | Yes | — | |
| 11079379 | Aug 27, 2035 | — | Yes | Yes | — | |
| 11141378 | Apr 15, 2029 | — | — | Yes | — | — |
| Code | Date | Status |
|---|---|---|
| M-270 | Jan 13, 2026 | Expired |